First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

Системные гипертензии

O. P. Rotar’¹  A. S. Galiavich²  T. R. Kameneva³  T. V. Martynyuk⁴  B. Sh. Gorieva⁵  V. O. Rodnenkov⁵  I. E. Chazova⁵  A. N. Rogoza⁵  L. A. Haisheva⁶  O. D. Ostroumova⁷  M. V. Arkhipov⁸  Yu. I. Grinshtein⁹ 

[1] Almazov National Medical Research Centre;Kazan State Medical University;Konchalovskiy City Clinical Hospital;Myasnikov Institute of Clinical Cardiology, National Medical Research Center for Cardiology, Moscow, Russia, Pirogov Russian National Research Medical University;Myasnikov Institute of Clinical Cardiology, National Medical Research Center for Cardiology;Rostov State Medical University;Russian Medical Academy of Continuous Professional Education;Ural State Medical University;Voino-Yasenetski Krasnoyarsk State Medical University;

关键词: victory ii;    russian clinical study;    arterial hypertension;    fixed combinations;    valsartan;    amlodipine;    hydrochlorothiazide;   

DOI  :  10.26442/2075082X.2020.2.200123

来源: DOAJ

【 授权许可】

Unknown